“…Polypeptides are synthetic analogues of natural proteins with excellent biocompatibility and biodegradability and have shown wide utilities in the biomedical field. Amphiphilic, polypeptide-based diblock copolymers, such as poly(ethylene glycol) (PEG)- block -polypeptides, can self-assemble into nanostructures that serve as promising vehicles for drug delivery. − The versatile side chain design of synthetic polypeptides allows facile incorporation of trigger-responsive moieties, which enable controlled release of encapsulated cargos from polypeptide-based nanocarriers. − Additionally, polypeptides adopt unique secondary structures, such as α-helix and β-sheet, which are also closely associated with the structure and function of polypeptide-based nanovehicles. − Sulfur-containing polypeptides, including those with disulfide and thioether side chains, are widely studied as the building blocks of polypeptide-based nanoassemblies, mainly due to their redox responsiveness that triggers the structural change of the nanocarriers and subsequently promotes the release of cargos. − Specifically, thioethers on polypeptide side chains can be oxidized to sulfoxide or sulfone groups by reactive oxygen species (ROS), resulting in significant changes in the side-chain polarity, hydrophilicity, and even the backbone secondary structure . As a result, amphiphilic block copolymer assemblies based on thioether-containing polypeptides can experience ROS-responsive structural change and subsequently lead to the release of the encapsulated payloads. − Nevertheless, oxidation of thioether usually requires a relatively high concentration of ROS (typically 10% H 2 O 2 , v/v), which greatly limits its application in the in vivo environment.…”